These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18559840)

  • 41. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis.
    Long EF
    PLoS One; 2011; 6(11):e27625. PubMed ID: 22110698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK.
    Moeremans K; Annemans L; Löthgren M; Allegri G; Wyffels V; Hemmet L; Caekelbergh K; Smets E
    Pharmacoeconomics; 2010; 28 Suppl 1():107-28. PubMed ID: 21182347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness of digital mammography breast cancer screening.
    Tosteson AN; Stout NK; Fryback DG; Acharyya S; Herman BA; Hannah LG; Pisano ED;
    Ann Intern Med; 2008 Jan; 148(1):1-10. PubMed ID: 18166758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness.
    Weinstein MC; Goldie SJ; Losina E; Cohen CJ; Baxter JD; Zhang H; Kimmel AD; Freedberg KA
    Ann Intern Med; 2001 Mar; 134(6):440-50. PubMed ID: 11255519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings.
    Hutchinson AB; Patel P; Sansom SL; Farnham PG; Sullivan TJ; Bennett B; Kerndt PR; Bolan RK; Heffelfinger JD; Prabhu VS; Branson BM
    PLoS Med; 2010 Sep; 7(9):e1000342. PubMed ID: 20927354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK.
    Brogan AJ; Talbird SE; Davis AE; Wild L; Flanagan D
    HIV Med; 2019 Nov; 20(10):668-680. PubMed ID: 31392813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
    Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
    JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.
    JAMA; 1998 Nov; 280(20):1757-63. PubMed ID: 9842951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years.
    Le P; Rothberg MB
    Ann Intern Med; 2015 Oct; 163(7):489-97. PubMed ID: 26344036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
    Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
    Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cost-effectiveness of the HIV screening program carried out in Guangxi Zhuang Autonomous Region infectious disease special demonstration project areas].
    Lu H; Luo L; Chen L; Zhang S; Liang Y; Li L; Chen Z; Huo X; Wu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jun; 36(6):580-3. PubMed ID: 26564628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
    Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
    Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.
    Dowdy DW; Rodriguez RM; Hare CB; Kaplan B
    Acad Emerg Med; 2011 Jul; 18(7):745-53. PubMed ID: 21762236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Routine HIV screening in France: clinical impact and cost-effectiveness.
    Yazdanpanah Y; Sloan CE; Charlois-Ou C; Le Vu S; Semaille C; Costagliola D; Pillonel J; Poullié AI; Scemama O; Deuffic-Burban S; Losina E; Walensky RP; Freedberg KA; Paltiel AD
    PLoS One; 2010 Oct; 5(10):e13132. PubMed ID: 20976112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA.
    Juusola JL; Brandeau ML; Long EF; Owens DK; Bendavid E
    AIDS; 2011 Sep; 25(14):1779-87. PubMed ID: 21716076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.
    Wong FL; Bhatia S; Landier W; Francisco L; Leisenring W; Hudson MM; Armstrong GT; Mertens A; Stovall M; Robison LL; Lyman GH; Lipshultz SE; Armenian SH
    Ann Intern Med; 2014 May; 160(10):672-83. PubMed ID: 24842414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
    Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
    Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.